Notice of Change to Eligible Organizations in PAR-22-250 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)"
National Institutes of Health
Type
Research/project funding
Posted on:
Notice NOT-GM-23-002 from the NIH Guide for Grants and Contracts